• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov6
Daniel Brennan Maintains Buy Rating for Pacific Biosciences
12:07
Pacific Biosc California released FY2025 9 Months Earnings on November 5 After-Market (EST), actual revenue USD 115.36M, actual EPS USD -1.71
00:00
Pacific Biosc California released FY2025 Q3 earnings on November 5 After-Market (EST), actual revenue USD 38.44M (forecast USD 40.25M), actual EPS USD -0.13 (forecast USD -0.1465)
00:00
Nov4
NMPA Approves Sequel II CNDx System for Thalassemia Diagnosis
14:34
Oct29
Pacific Biosc California to Release FY2025 Q3 Earnings on November 5 After-Market EST, Forecast Revenue USD 40.25 M, EPS USD -0.152
00:38
Oct27
Mikson CFA Rates Pacific Biosciences and Other Stocks
11:37

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 38.44 M, Net Income -38 M, EPS -0.13

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 39.77 M, Net Income -41.93 M, EPS -0.14

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 37.15 M, Net Income -426.08 M, EPS -1.44

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More